IL10 and chronic asthma: Interestingly, the use of Gal-3 therapy has also shown positive results on murine models simulating chronic asthma, with a significant reduction in key BAL cytokines like IL-5, interleukin-4 (IL-4), and interleukin-10 (IL-10).